Physiologically-Based Pharmacokinetic Modeling-Guided Dose Management of Oral Anticoagulants when Initiating Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 Treatment. | Clin Pharmacol Ther;112(4): 803-807, 2022 10. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Physiologically-Based Pharmacokinetic Modeling-Guided Dose Management of Oral Anticoagulants when Initiating Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 Treatment.

Wang, Ziteng; Chan, Eric Chun Yong.

Affiliation

Wang Z; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.
Chan ECY; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore, Singapore.

Clin Pharmacol Ther ; 112(4): 803-807, 2022 10.

Article in En | MEDLINE | ID: mdl-35712802

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ritonavir / COVID-19 Drug Treatment Type of study: Observational_studies Limits: Aged / Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ritonavir / COVID-19 Drug Treatment Type of study: Observational_studies Limits: Aged / Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Document type: Article Affiliation country: Country of publication: